Camargo Appoints COO - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Camargo Appoints COO



Untitled Document

Jim Beach, a veteran health care executive, has been named chief operating officer for Camargo Pharmaceutical Services, a drug- development organization specializing in the 505(b)(2) approval pathway.

Prior to joining Camargo, Beach had been vice-president of marketing and product management for scientific products for Cardinal Health, vice-president of market insights and a member of the US management board for Ethicon Endo-Surgery, and leader of the global product company program for GE Healthcare.

Source: Camargo Pharmaceutical Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here